These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 10935479)
1. Chromosomal and extrachromosomal instability of the cyclin D2 gene is induced by Myc overexpression. Mai S; Hanley-Hyde J; Rainey GJ; Kuschak TI; Paul JT; Littlewood TD; Mischak H; Stevens LM; Henderson DW; Mushinski JF Neoplasia; 1999 Aug; 1(3):241-52. PubMed ID: 10935479 [TBL] [Abstract][Full Text] [Related]
2. Myc-induced cyclin D2 genomic instability in murine B cell neoplasms. Mushinski JF; Hanley-Hyde J; Rainey GJ; Kuschak TI; Taylor C; Fluri M; Stevens LM; Henderson DW; Mai S Curr Top Microbiol Immunol; 1999; 246():183-9; discussion 190-2. PubMed ID: 10396055 [No Abstract] [Full Text] [Related]
3. Cyclin gene amplification and overexpression in breast and ovarian cancers: evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors. Courjal F; Louason G; Speiser P; Katsaros D; Zeillinger R; Theillet C Int J Cancer; 1996 Aug; 69(4):247-53. PubMed ID: 8797862 [TBL] [Abstract][Full Text] [Related]
4. FISH is more sensitive than Southern analysis at identifying increased levels of cyclin D1 gene amplified in breast cancer cell lines. Dongsong N; Zhou JY Mol Biol Rep; 2010 Oct; 37(7):3473-80. PubMed ID: 19967453 [TBL] [Abstract][Full Text] [Related]
6. Detection of N-myc gene amplification by fluorescence in situ hybridization. Diagnostic utility for neuroblastoma. Shapiro DN; Valentine MB; Rowe ST; Sinclair AE; Sublett JE; Roberts WM; Look AT Am J Pathol; 1993 May; 142(5):1339-46. PubMed ID: 7684192 [TBL] [Abstract][Full Text] [Related]
7. Activation of cyclin D1 and D2 promoters by human T-cell leukemia virus type I tax protein is associated with IL-2-independent growth of T cells. Mori N; Fujii M; Hinz M; Nakayama K; Yamada Y; Ikeda S; Yamasaki Y; Kashanchi F; Tanaka Y; Tomonaga M; Yamamoto N Int J Cancer; 2002 May; 99(3):378-85. PubMed ID: 11992406 [TBL] [Abstract][Full Text] [Related]
8. The ribonucleotide reductase R2 gene is a non-transcribed target of c-Myc-induced genomic instability. Kuschak TI; Taylor C; McMillan-Ward E; Israels S; Henderson DW; Mushinski JF; Wright JA; Mai S Gene; 1999 Oct; 238(2):351-65. PubMed ID: 10570963 [TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of cyclin D2 is an early event in human male germ cell tumorigenesis. Houldsworth J; Reuter V; Bosl GJ; Chaganti RS Cell Growth Differ; 1997 Mar; 8(3):293-9. PubMed ID: 9056671 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Jiang W; Kahn SM; Zhou P; Zhang YJ; Cacace AM; Infante AS; Doi S; Santella RM; Weinstein IB Oncogene; 1993 Dec; 8(12):3447-57. PubMed ID: 8247550 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of cyclin D2 in chronic B-cell malignancies. Delmer A; Ajchenbaum-Cymbalista F; Tang R; Ramond S; Faussat AM; Marie JP; Zittoun R Blood; 1995 May; 85(10):2870-6. PubMed ID: 7742549 [TBL] [Abstract][Full Text] [Related]
12. Expression of D-type cyclins in normal and neoplastic rat pituitary. Qian X; Kulig E; Jin L; Lloyd RV Endocrinology; 1998 Apr; 139(4):2058-67. PubMed ID: 9528994 [TBL] [Abstract][Full Text] [Related]
13. Amplified extrachromosomal elements containing c-Myc and Pvt 1 in a mouse plasmacytoma. Mai S; Hanley-Hyde J; Coleman A; Siwarski D; Huppi K Genome; 1995 Aug; 38(4):780-5. PubMed ID: 7672608 [TBL] [Abstract][Full Text] [Related]
14. Phenotype-related differences in the expression of D-type cyclins in human B cell-derived lines. Pokrovskaja K; Ehlin-Henriksson B; Bartkova J; Bartek J; Scuderi R; Szekely L; Wiman KG; Klein G Cell Growth Differ; 1996 Dec; 7(12):1723-32. PubMed ID: 8959341 [TBL] [Abstract][Full Text] [Related]
15. Amplification of the translocated c-myc genes in three Burkitt lymphoma cell lines. Khaira P; James CD; Leffak M Gene; 1998 Apr; 211(1):101-8. PubMed ID: 9643977 [TBL] [Abstract][Full Text] [Related]
16. Expression of cyclin Ds in relation to p53 status in human breast carcinomas. Bukholm IK; Berner JM; Nesland JM; Børresen-Dale AL Virchows Arch; 1998 Sep; 433(3):223-8. PubMed ID: 9769125 [TBL] [Abstract][Full Text] [Related]
17. Development of mice expressing a single D-type cyclin. Ciemerych MA; Kenney AM; Sicinska E; Kalaszczynska I; Bronson RT; Rowitch DH; Gardner H; Sicinski P Genes Dev; 2002 Dec; 16(24):3277-89. PubMed ID: 12502747 [TBL] [Abstract][Full Text] [Related]
18. Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27. Bouchard C; Thieke K; Maier A; Saffrich R; Hanley-Hyde J; Ansorge W; Reed S; Sicinski P; Bartek J; Eilers M EMBO J; 1999 Oct; 18(19):5321-33. PubMed ID: 10508165 [TBL] [Abstract][Full Text] [Related]
19. Cyclins D1 and D2 are differentially expressed in human B-lymphoid cell lines. Palmero I; Holder A; Sinclair AJ; Dickson C; Peters G Oncogene; 1993 Apr; 8(4):1049-54. PubMed ID: 8455931 [TBL] [Abstract][Full Text] [Related]
20. Ras and Myc can drive oncogenic cell proliferation through individual D-cyclins. Yu Q; Ciemerych MA; Sicinski P Oncogene; 2005 Oct; 24(47):7114-9. PubMed ID: 16103884 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]